APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enzalutamide Tablets Market Outlook and Growth Opportunities 2026

29 December 2025192 pages

Choose your research edition.

Industry ResearchEnzalutamide Tablets Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Tablets Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Enzalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Enzalutamide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enzalutamide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enzalutamide Tablets market include Astellas/Pfizer and AURISCO among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enzalutamide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzalutamide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzalutamide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enzalutamide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Enzalutamide Tablets Segment by Company

Astellas/Pfizer

AURISCO

Enzalutamide Tablets Segment by Type

40mg

80mg

Enzalutamide Tablets Segment by Application

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Castration- Resistant Prostate Cancer (NM-CRPC)

Enzalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enzalutamide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Enzalutamide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enzalutamide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Enzalutamide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enzalutamide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enzalutamide Tablets industry.

Chapter 3: Detailed analysis of Enzalutamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Enzalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Enzalutamide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enzalutamide Tablets Industry Trends Table 2. Enzalutamide Tablets Industry Drivers Table 3. Enzalutamide Tablets Industry Opportunities and Challenges Table 4. Enzalutamide Tablets Industry Restraints Table 5. Global Enzalutamide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enzalutamide Tablets Revenue Share by Company (2021-2026) Table 7. Global Enzalutamide Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Enzalutamide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Enzalutamide Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Enzalutamide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Enzalutamide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Enzalutamide Tablets Company, Product Type & Application Table 13. Global Enzalutamide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Enzalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Table 18. Significant Companies of 80mg Table 19. Global Enzalutamide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Enzalutamide Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Enzalutamide Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Enzalutamide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Enzalutamide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Enzalutamide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Enzalutamide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Enzalutamide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Enzalutamide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Enzalutamide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Table 30. Significant Companies of Castration- Resistant Prostate Cancer (NM-CRPC) Table 31. Global Enzalutamide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Enzalutamide Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Enzalutamide Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Enzalutamide Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Enzalutamide Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Enzalutamide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Enzalutamide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Enzalutamide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Enzalutamide Tablets Sales Value Share by Application (2021-2026) Table 40. Global Enzalutamide Tablets Sales Value Share by Application (2027-2032) Table 41. Global Enzalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Enzalutamide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Enzalutamide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Enzalutamide Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Enzalutamide Tablets Sales Market Share by Region (2027-2032) Table 46. Global Enzalutamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Enzalutamide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Enzalutamide Tablets Sales Value Share by Region (2021-2026) Table 49. Global Enzalutamide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Enzalutamide Tablets Sales Value Share by Region (2027-2032) Table 51. Global Enzalutamide Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Enzalutamide Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Enzalutamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 57. Global Enzalutamide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Enzalutamide Tablets Sales Market Share by Country (2027-2032) Table 59. Global Enzalutamide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Enzalutamide Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Enzalutamide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Enzalutamide Tablets Sales Value Market Share by Country (2027-2032) Table 63. Astellas/Pfizer Company Information Table 64. Astellas/Pfizer Business Overview Table 65. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Astellas/Pfizer Enzalutamide Tablets Product Portfolio Table 67. Astellas/Pfizer Recent Development Table 68. AURISCO Company Information Table 69. AURISCO Business Overview Table 70. AURISCO Enzalutamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AURISCO Enzalutamide Tablets Product Portfolio Table 72. AURISCO Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Enzalutamide Tablets Distributors List Table 76. Enzalutamide Tablets Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Enzalutamide Tablets Product Image Figure 2. Global Enzalutamide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Enzalutamide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Enzalutamide Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Enzalutamide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Image Figure 10. 80mg Image Figure 11. Global Enzalutamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Enzalutamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Enzalutamide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Enzalutamide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Enzalutamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Enzalutamide Tablets Sales Value Share by Type (2021-2032) Figure 17. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Image Figure 18. Castration- Resistant Prostate Cancer (NM-CRPC) Image Figure 19. Global Enzalutamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Enzalutamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Enzalutamide Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Enzalutamide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Enzalutamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Enzalutamide Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Enzalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Enzalutamide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Enzalutamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Enzalutamide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Enzalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Enzalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Enzalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Enzalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Enzalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Enzalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Enzalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Enzalutamide Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Enzalutamide Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Castration- Resistant Prostate Cancer (NM-CRPC)
Companies covered
  • Astellas/Pfizer
  • AURISCO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzalutamide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Enzalutamide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Enzalutamide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Enzalutamide Tablets Market Dynamics
  1. 2.1 Enzalutamide Tablets Industry Trends
  2. 2.2 Enzalutamide Tablets Industry Drivers
  3. 2.3 Enzalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Tablets Industry Restraints
3 Enzalutamide Tablets Market by Company
  1. 3.1 Global Enzalutamide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Enzalutamide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Enzalutamide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Enzalutamide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Enzalutamide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Enzalutamide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Enzalutamide Tablets Company Product Type and Application
  8. 3.8 Global Enzalutamide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Enzalutamide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Enzalutamide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Enzalutamide Tablets Market by Type
  1. 4.1 Enzalutamide Tablets Type Introduction
  2. 4.1.1 40mg
  3. 4.1.2 80mg
  4. 4.2 Global Enzalutamide Tablets Sales Volume by Type
  5. 4.2.1 Global Enzalutamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Enzalutamide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Enzalutamide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Enzalutamide Tablets Sales Value by Type
  9. 4.3.1 Global Enzalutamide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Enzalutamide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Enzalutamide Tablets Sales Value Share by Type (2021-2032)
5 Enzalutamide Tablets Market by Application
  1. 5.1 Enzalutamide Tablets Application Introduction
  2. 5.1.1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  3. 5.1.2 Castration- Resistant Prostate Cancer (NM-CRPC)
  4. 5.2 Global Enzalutamide Tablets Sales Volume by Application
  5. 5.2.1 Global Enzalutamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Enzalutamide Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Enzalutamide Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Enzalutamide Tablets Sales Value by Application
  9. 5.3.1 Global Enzalutamide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Enzalutamide Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Enzalutamide Tablets Sales Value Share by Application (2021-2032)
6 Enzalutamide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Enzalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzalutamide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Enzalutamide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Enzalutamide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Enzalutamide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Enzalutamide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Enzalutamide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Enzalutamide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Enzalutamide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Enzalutamide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Enzalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Enzalutamide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Enzalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Enzalutamide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Enzalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Enzalutamide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Enzalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Enzalutamide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Enzalutamide Tablets Sales Value Share by Country, 2025 VS 2032
7 Enzalutamide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enzalutamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Enzalutamide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Enzalutamide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Enzalutamide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Enzalutamide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Enzalutamide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Enzalutamide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Enzalutamide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Enzalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Enzalutamide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas/Pfizer
  2. 8.1.1 Astellas/Pfizer Company Information
  3. 8.1.2 Astellas/Pfizer Business Overview
  4. 8.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Astellas/Pfizer Enzalutamide Tablets Product Portfolio
  6. 8.1.5 Astellas/Pfizer Recent Developments
  7. 8.2 AURISCO
  8. 8.2.1 AURISCO Company Information
  9. 8.2.2 AURISCO Business Overview
  10. 8.2.3 AURISCO Enzalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AURISCO Enzalutamide Tablets Product Portfolio
  12. 8.2.5 AURISCO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enzalutamide Tablets Value Chain Analysis
  2. 9.1.1 Enzalutamide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enzalutamide Tablets Sales Mode & Process
  6. 9.2 Enzalutamide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enzalutamide Tablets Distributors
  9. 9.2.3 Enzalutamide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst